Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Research Report 2017

Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Research Report 2017

1 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Overview

1.1 Product Overview and Scope of High Potency Active Pharmaceutical Ingredients (HPAPI)

1.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Segment by Type (Product Category)

1.2.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)

1.2.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Type (Product Category) in 2016

1.2.3 Synthetic

1.2.4 Biotech

1.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Segment by Application

1.3.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (Sales) Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Hormonal

1.3.4 Glaucoma

1.3.5 Others

1.4 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market by Region (2012-2022)

1.4.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)

1.4.2 North America Status and Prospect (2012-2022)

1.4.3 Europe Status and Prospect (2012-2022)

1.4.4 China Status and Prospect (2012-2022)

1.4.5 Japan Status and Prospect (2012-2022)

1.4.6 Southeast Asia Status and Prospect (2012-2022)

1.4.7 India Status and Prospect (2012-2022)

1.5 Global Market Size (Value) of High Potency Active Pharmaceutical Ingredients (HPAPI) (2012-2022)

1.5.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Status and Outlook (2012-2022)

1.5.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production Status and Outlook (2012-2022)

2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Competition by Manufacturers

2.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production and Share by Manufacturers (2012-2017)

2.1.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity and Share by Manufacturers (2012-2017)

2.1.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production and Share by Manufacturers (2012-2017)

2.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Share by Manufacturers (2012-2017)

2.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price by Manufacturers (2012-2017)

2.4 Manufacturers High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution, Sales Area and Product Type

2.5 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Competitive Situation and Trends

2.5.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Concentration Rate

2.5.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue (Value) by Region (2012-2017)

3.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity and Market Share by Region (2012-2017)

3.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production and Market Share by Region (2012-2017)

3.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Value) and Market Share by Region (2012-2017)

3.4 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.5 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.6 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.7 China High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.8 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.9 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

3.10 India High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Supply (Production), Consumption, Export, Import by Region (2012-2017)

4.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption by Region (2012-2017)

4.2 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

4.3 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

4.4 China High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

4.5 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

4.6 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

4.7 India High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export, Import (2012-2017)

5 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue (Value), Price Trend by Type

5.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production and Market Share by Type (2012-2017)

5.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Market Share by Type (2012-2017)

5.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Price by Type (2012-2017)

5.4 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth by Type (2012-2017)

6 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Analysis by Application

6.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption and Market Share by Application (2012-2017)

6.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Growth Rate by Application (2012-2017)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturers Profiles/Analysis

7.1 Eli Lilly and Company

7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.1.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.1.2.1 Product A

7.1.2.2 Product B

7.1.3 Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.1.4 Main Business/Business Overview

7.2 Novartis International AG

7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.2.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.2.2.1 Product A

7.2.2.2 Product B

7.2.3 Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.2.4 Main Business/Business Overview

7.3 Bristol-Myers Squibb Company

7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.3.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.3.2.1 Product A

7.3.2.2 Product B

7.3.3 Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.3.4 Main Business/Business Overview

7.4 Roche Diagnostics Limited

7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.4.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.4.2.1 Product A

7.4.2.2 Product B

7.4.3 Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.4.4 Main Business/Business Overview

7.5 Sanofi Aventis

7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.5.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.5.2.1 Product A

7.5.2.2 Product B

7.5.3 Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.5.4 Main Business/Business Overview

7.6 Hospira, Inc.

7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.6.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.6.2.1 Product A

7.6.2.2 Product B

7.6.3 Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.6.4 Main Business/Business Overview

7.7 BASF AG

7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.7.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.7.2.1 Product A

7.7.2.2 Product B

7.7.3 BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.7.4 Main Business/Business Overview

7.8 Covidien Plc

7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.8.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.8.2.1 Product A

7.8.2.2 Product B

7.8.3 Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.8.4 Main Business/Business Overview

7.9 Boehringer Ingelheim GmbH

7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.9.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.9.2.1 Product A

7.9.2.2 Product B

7.9.3 Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.9.4 Main Business/Business Overview

7.10 Merck & Co., Inc.

7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

7.10.2 High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category, Application and Specification

7.10.2.1 Product A

7.10.2.2 Product B

7.10.3 Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

7.10.4 Main Business/Business Overview

7.11 Sigma Aldrich Corporation

7.12 Bayer AG

7.13 Carbogen Amcis AG

7.14 Lonza

7.15 Teva Pharmaceuticals Industries Ltd.

8 High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturing Cost Analysis

8.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredients (HPAPI)

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 High Potency Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of High Potency Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Forecast (2017-2022)

12.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production, Revenue Forecast (2017-2022)

12.1.1 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production and Growth Rate Forecast (2017-2022)

12.1.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue and Growth Rate Forecast (2017-2022)

12.1.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Price and Trend Forecast (2017-2022)

12.2 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption , Import and Export Forecast by Region (2017-2022)

12.2.1 North America High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.2 Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.3 China High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.4 Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.5 Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.2.6 India High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue, Consumption, Export and Import Forecast (2017-2022)

12.3 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Revenue and Price Forecast by Type (2017-2022)

12.4 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology/Research Approach

14.1.1 Research Programs/Design

14.1.2 Market Size Estimation

14.1.3 Market Breakdown and Data Triangulation

14.2 Data Source

14.2.1 Secondary Sources

14.2.2 Primary Sources

14.3 Disclaimer

Figure Picture of High Potency Active Pharmaceutical Ingredients (HPAPI)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Types (Product Category) in 2016

Figure Product Picture of Synthetic

Table Major Manufacturers of Synthetic

Figure Product Picture of Biotech

Table Major Manufacturers of Biotech

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) by Applications (2012-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Applications in 2016

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Hormonal Examples

Table Key Downstream Customer in Hormonal

Figure Glaucoma Examples

Table Key Downstream Customer in Glaucoma

Figure Others Examples

Table Key Downstream Customer in Others

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)

Figure North America High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure China High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure India High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate (2012-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Status and Outlook (2012-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units) Status and Outlook (2012-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Major Players Product Capacity (K Units) (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity (K Units) of Key Manufacturers (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity Market Share of Key Manufacturers (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity (K Units) of Key Manufacturers in 2016

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity (K Units) of Key Manufacturers in 2017

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Major Players Product Production (K Units) (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) of Key Manufacturers (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Share by Manufacturers (2012-2017)

Figure 2016 High Potency Active Pharmaceutical Ingredients (HPAPI) Production Share by Manufacturers

Figure 2017 High Potency Active Pharmaceutical Ingredients (HPAPI) Production Share by Manufacturers

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Major Players Product Revenue (Million USD) (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Manufacturers (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers (2012-2017)

Table 2016 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers

Table 2017 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Manufacturers

Table Global Market High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/Unit) of Key Manufacturers (2012-2017)

Figure Global Market High Potency Active Pharmaceutical Ingredients (HPAPI) Average Price (USD/Unit) of Key Manufacturers in 2016

Table Manufacturers High Potency Active Pharmaceutical Ingredients (HPAPI) Manufacturing Base Distribution and Sales Area

Table Manufacturers High Potency Active Pharmaceutical Ingredients (HPAPI) Product Category

Figure High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 3 Manufacturers

Figure High Potency Active Pharmaceutical Ingredients (HPAPI) Market Share of Top 5 Manufacturers

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity (K Units) by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity Market Share by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity Market Share by Region (2012-2017)

Figure 2016 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity Market Share by Region

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Region (2012-2017)

Figure 2016 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share by Region

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Region (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region (2012-2017)

Table 2016 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share by Region

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units) and Growth Rate (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table North America High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table China High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table India High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) Market by Region (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Region (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Region (2012-2017)

Figure 2016 Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) Market Share by Region

Table North America High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table China High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table India High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Import & Export (K Units) (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) by Type (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Share by Type (2012-2017)

Figure Production Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure 2016 Production Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) by Type (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Share by Type (2012-2017)

Figure Production Revenue Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type (2012-2017)

Figure 2016 Revenue Market Share of High Potency Active Pharmaceutical Ingredients (HPAPI) by Type

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Price (USD/Unit) by Type (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth by Type (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) by Application (2012-2017)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Application (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Applications (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share by Application in 2016

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Growth Rate by Application (2012-2017)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Growth Rate by Application (2012-2017)

Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Eli Lilly and Company High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Novartis International AG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Novartis International AG High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Bristol-Myers Squibb Company High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Roche Diagnostics Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Roche Diagnostics Limited High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Sanofi Aventis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Sanofi Aventis High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Hospira, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Hospira, Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table BASF AG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure BASF AG High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Covidien Plc Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Covidien Plc High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Boehringer Ingelheim GmbH High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Production Growth Rate (2012-2017)

Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share (2012-2017)

Figure Merck & Co., Inc. High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of High Potency Active Pharmaceutical Ingredients (HPAPI)

Figure Manufacturing Process Analysis of High Potency Active Pharmaceutical Ingredients (HPAPI)

Figure High Potency Active Pharmaceutical Ingredients (HPAPI) Industrial Chain Analysis

Table Raw Materials Sources of High Potency Active Pharmaceutical Ingredients (HPAPI) Major Manufacturers in 2016

Table Major Buyers of High Potency Active Pharmaceutical Ingredients (HPAPI)

Table Distributors/Traders List

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Price (Million USD) and Trend Forecast (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) Forecast by Region (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production Market Share Forecast by Region (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) Forecast by Region (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption Market Share Forecast by Region (2017-2022)

Figure North America High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure North America High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table North America High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Europe High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure China High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure China High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table China High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Japan High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table Southeast Asia High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Figure India High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) and Growth Rate Forecast (2017-2022)

Figure India High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Table India High Potency Active Pharmaceutical Ingredients (HPAPI) Production, Consumption, Export and Import (K Units) Forecast (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) Forecast by Type (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Production (K Units) Forecast by Type (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue (Million USD) Forecast by Type (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Revenue Market Share Forecast by Type (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Price Forecast by Type (2017-2022)

Table Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) Forecast by Application (2017-2022)

Figure Global High Potency Active Pharmaceutical Ingredients (HPAPI) Consumption (K Units) Forecast by Application (2017-2022)

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Source